" class="no-js "lang="en-US"> Novavax to Participate in Fireside Chat at Goldman Sachs Virtual Conference - Medtech Alert
Wednesday, March 29, 2023

Breaking News

Coeptis Therapeutics Secures Exclusive Rights to Negotiate the Acquisition of Transformational Cell Therapy Platform SamaCare Partners with AmerisourceBergen to Offer Prior Authorization Platform to Specialty Practices Lucy Therapeutics Appoints Neuroscience Drug Discovery and Development Expert Christopher J. Winrow, Ph.D., as Chief Scientific Officer BGI Genomics Partners with Zentya to Launch Fecal DNA Test for Colorectal Cancer in Slovakia PharmaVentures Establishes an Office in Seoul to Enhance Access for South Korean Biotechs Genialis Raises $13M in Financing to Build Clinical Biomarkers that Predict Patient Response Pharmaron’s Liverpool UK Gene Therapy CDMO Commences Major Site Expansion Following UK Government Grant to Support £151m Investment Lantern Pharma Announces First Patient Dosed in Study for LP-300 in Never Smokers with Advanced Non-Small Cell Lung Cancer Transcenta’s Osemitamab (TST001) Targeting Claudin18.2 Granted Orphan Drug Designation for Treatment of Pancreatic Cancer MIMETAS and Astellas Enter into Strategic Partnership
Novavax to Participate in Fireside Chat at Goldman Sachs Virtual Conference | Pharmtech Focus

April 8 2021

Novavax to Participate in Fireside Chat at Goldman Sachs Virtual Conference

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that it will participate in a fireside chat during the Goldman Sachs Recovery Inoculated: The Current Outlook for COVID-19 Vaccines, Treatments, Testing and the Economy virtual conference. Novavax’ COVID-19 vaccine candidate, NVX-CoV2373, will be a topic of discussion.

Fireside chat details:
Date: Tuesday, April 13, 2021
Time: 2:30 – 3:20 p.m. Eastern Time (ET)
Panel title: COVID-19 Vaccines – Staying Ahead of the Curve
Novavax participant: Vivek Shinde, M.D., M.P.H., Vice President, Clinical Development
This event is open to Goldman Sachs clients.

Companies In This Post

Novavax | Pharmtech Focus

Novavax
  1. Coeptis Therapeutics Secures Exclusive Rights to Negotiate the Acquisition of Transformational Cell Therapy Platform

    Diseases

     Read more
  2. SamaCare Partners with AmerisourceBergen to Offer Prior Authorization Platform to Specialty Practices

    News

     Read more
  3. Lucy Therapeutics Appoints Neuroscience Drug Discovery and Development Expert Christopher J. Winrow, Ph.D., as Chief Scientific Officer

    Drug Development

     Read more
  4. BGI Genomics Partners with Zentya to Launch Fecal DNA Test for Colorectal Cancer in Slovakia

    News

     Read more
  5. PharmaVentures Establishes an Office in Seoul to Enhance Access for South Korean Biotechs

    News

     Read more
More On